Nasdaq
MNPR
Monopar Therapeutics Inc.
- Health Care
- Listed 2019
- 1 day
- +0.8%
- 1 month
- +26.2%
- 1 year
- +196%
$120.21 · Mkt cap $805M
At the 6 Aug 2026 close
Nasdaq
Monopar Therapeutics Inc.
$120.21 · Mkt cap $805M
At the 6 Aug 2026 close
Monopar Therapeutics Inc. trades under the ticker MNPR on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2019. Its market capitalisation is $805M. The last closing price was $120.21, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +196%, and +26.2% over the past month. Returns are price returns and exclude dividends.
This page exists because MNPR is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.